The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

Introduction

Neem extract market on a rapid growth trajectory.

Forecasted to reach $3 billion in 2024.

Driving Forces Behind Market Growth

Traditional medicinal uses and natural pest control.

Demand from skin care and cosmetics industry.

Increasing awareness of health benefits.

Environmentally friendly biopesticides.

Future Projections and Trends

Expected to reach $4.89 billion by 2028.

Rising demand in personal care products and organic farming.

Government initiatives supporting herbal products.

Emergence of neem-based functional foods.

Demand for Organic Products Fueling Growth

Neem extract utilized in various sectors.

Antibacterial and antifungal properties make it ideal.

Increasing demand for organic products.

Read More On The Neem Extract Market Report 2024 – https://www.thebusinessresearchcompany.com/report/neem-extract-global-market-report

Product Innovation Boosts Market

Companies developing new products.

Example: Nisarga Neem Capsules for COVID-19 prevention.

Clinically validated and patented.

Enhances immunity and general health.

Market Expansion Through Acquisitions

Example: Indorama India acquiring Indo Gulf Fertilizers.

Provides complete variety of agricultural products.

Indo Gulf Fertilizers manufactures neem extracts.

Market Segmentation
By Type: Leaf Extract, Fruit And Seed Extract, Bark Extract

By Formulation: Dry, Liquid

By Application: Food And Beverages, Pharmaceutical, Nutraceutical, Personal Care And Cosmetics, Agriculture And Farming, Other Applications

Asia-Pacific leading region, Western Europe fastest-growing.

The Neutropenia Biologic Drug Market: Battling Cancer

Cancer Epidemic Driving Market Growth

Increase in cancer cases globally.

Rise in neutropenia cases due to chemotherapy.

Anticipated boost in demand for biologic drugs.

Biosimilars Pose Challenges

Patent expiry leading to biosimilar introduction.

Biosimilars priced lower than branded drugs.

Example: Biocon Biologics’ Abevmy for cancer treatment.

Strategic Acquisitions Expand Market Reach

Example: Biocon Biologics acquiring Viatris.

Strengthening capabilities in biosimilars market.

Viatris develops neutropenia biologic drugs.

Market Segmentation

By Drug Type: Filgrastim, Pegfilgrastim, Lenograstim, Lipegfilgrastim, Sargramostim

By Treatment Type: Antibiotic Drugs, Granulocyte-Colony-Stimulating Factor (G-CSF), Antifungal Drugs, Other Treatment Types

By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies

North America leading region in 2023.

Conclusion

Both neem extract and neutropenia biologic drug markets poised for significant growth.

Driven by diverse factors including health awareness, market access, and technological advancements.

These markets represent the convergence of innovation and sustainability in meeting global healthcare and environmental challenges.

Request for A Sample Of The Global Neem Extract Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=10818&type=smp